TrialThe oncologist2015

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.

Mehmet Asim Bilen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.